| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Semba Charles Pauling is a Director at DiaMedica Therapeutics Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $313K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2023 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 12,787 | $3.91 | $49,997.17 | +74.5% | -29.4% | -49.2% |